Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

Dave, there has been no evidence that Gerald is ta

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
Posted On: 08/13/2014 1:17:16 PM
Avatar
Posted By: Warp
Re: Daveludlow #3688
Dave, there has been no evidence that Gerald is targeting a $4 share price which would result from your 1:40 RS scenario at 10 cents. The only number he's ever mentioned regarding uplisting came from last year's conference call where he specifically mentioned the $2 requirement.

I understand your thoughts on the $4 or $5 price required to purchase on margin, but I don't seriously believe Gerald would intentionally reduce his own or his father's shares by an additional factor of 2 just to satisfy those wanting to buy on margin, including the brokers.

If an investor required a $4 price to buy on margin, and wanted to invest $1M at 50% margin, he could effectively buy $2M in shares, equaling 500,000 shares bought on margin.

If the initial listing price was only $2 and the broker couldn't buy on margin due to the price being below the minimum margin able price, he would still be able to purchase 500,000 shares for the same $1M investment.

Sorry, but I don't see the advantage of the higher share price here when the numbers work out the same. Because of this, I don't feel Gerald will be compelled to uplist in the $4 or $5 range that has been suggested. With the buffer already built into the $1 minimum price to remain listed, and the 180 day buffer following a delisting notice if price falls below $1, I feel they will target any RS closer to the $2 price required to minimize their own and shareholder reduction in number of shares.

I do share your thoughts on waiting to see what catalysts are met before we vote. While I'm generally positive about the AS increase and the reasons, let's see if the company can deliver on expectations they set before voting for the increase.


(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us